New York woman, who underwent a potentially dangerous HIV treatment has been found to have been healed. Doctors have said that she is now free from the virus.
She is only known by her name, the “New York patient,”In 2013, she was diagnosed as having HIV and in 2017, developed leukemia. Although it seemed like she was in a hopeless situation, her leukemia made her the perfect candidate to receive a risky and rare stem-cell therapy.
Because of its high death rate, this procedure can only be offered to HIV-positive patients with late-stage or advanced stage cancer.
Doctors must obtain the umbilical cord blood from a donor who is immune to the disease in order to be able to give the treatment. Only 1% of the population is affected by this mutation, which is most common in northern Europeans.
In this instance, the umbilical cord blood is used and also bone marrow. ‘haploidentical cord transplantation’,This program aims at tackling both HIV/cancer in patients.
The cord blood fights blood-based tumors. While the bone marrow gives the body stem cells, the effect of the treatment is enhanced.
Four years ago, the New York Presbyterian Weill Cornell Medical Center performed the risky procedure on the female in question.
NBC reported that doctors had told NBC her body had reacted positively to the treatment and they were able to report positive results shortly thereafter.
The patient’s cancer had gone into remission, and a year ago she was able to discontinue her HIV treatment.
Since then, the woman has been tested multiple times and there have not been any signs that the virus is recurring. The woman’s cells were also collected by clinicians who tried to infect them with HIV using a laboratory. However, this was unsuccessful.
This is the point at which you can start to ‘New York patient’It is believed that she was the first woman and the fourth to ever be freed from the virus. Natural cures have been found in two other females.
However, doctors are not in a rush to declare victory. “You don’t want to over-call it,” Dr. Yvonne J. Bryson of UCLA’s David Geffen School of Medicine cautioned. According to her, “remission” would be a more preferable word to describe the woman’s condition at this moment.
It will take a few years before the official declaration can be made by medics. ‘New York patient’To be treated.
Dr. Bryson stated that she was still “excited” by the result of the stem-cell treatment, saying it’s given the researchers “more hope and more options for the future.”
The Stem Cell Transplant Program Director, Dr. Koen Vand Besien was her colleague. “approximately 50 patients per year in the US who could benefit from this procedure.”
Share this story via social media
[ad_2]
